journal article·2024-11-20

Study of Azobenzene-modified Black Phosphorus for Potential Tumor Therapy

Dong Zheng, Wenxi Li, Junchuan Liang, Xueping Wang, Maokai Yu, Huaizhu Wang, Xiuxiu Wang, Jing Zhao, Zhong Jin, Jing Ma

ACS Applied Materials & Interfaces· Volume 16· Issue 46
Publisher page

Abstract

Exploring the interaction between black phosphorus (BP)-based hybrid systems and target proteins is of great significance for understanding the biological effects of 2D nanomaterials at the molecular level. Density functional theory (DFT) calculations revealed that different terminal groups of the azobenzene (AB) motif in BP@AB hybrids can affect the extent of interfacial charge transfer between the BP sheet and AB-derivatives, which determines the electrostatic interaction with proteins and hence biofunctions of BP@AB hybrids. With the advantage of AB modification, BP@AB hybrids displayed antitumor effects and induced production of cellular reactive oxygen species and apoptosis in cancer cells. Through the proteomics profiling, cellular ribosome and lipid metabolic processes were screened out as the target pathways of the BP@AB-NH 2 in HeLa cells, while the BP@AB-S-S-AB system mainly targets the ERBB and PPAR signaling pathways. Molecular docking simulations revealed that due to the positive charge, ribosomal pathway proteins enriched in negatively charged amino acids such as lysine and arginine are preferentially adsorbed and bound by BP@AB-NH 2 hybrids. Whereas for BP@AB-S-S-AB, receptors containing narrow and long pocket domains are more likely to bind with BP@AB-S-S-AB by van der Waals forces for the rod-like hybrids. Different biomolecule targeting and action modes of BP@AB hybrids have been rationalized by different electrostatic environments and matching of geometric configurations, shedding insight for designing efficient and targeted modification of a 2D nanomaterial-based strategy for cancer therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Dendrimers and Hyperbranched Polymers · Photochromic and Fluorescence Chemistry · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

National Laboratory of Solid State Microstructures, Collaborative Innovation Center of Advanced Microstructures, and School of Physics, Nanjing University, Nanjing 210093, P. R. China

Atom Manufacturing Institute (AMI), Nanjing 211805, P. R. China

State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, P. R.China

School of Life Sciences, Nanjing University, Nanjing, 210023, P. R. China

Chemistry and Biomedicine Innovation Center (ChemBIC), Nanjing University, Nanjing, 210023, P. R. China

Funding

National Key Research and Development Program of China · Natural Science Foundation of Jiangsu Province · Fundamental Research Funds for the Central Universities · National Natural Science Foundation of China · Scientific and Technological Achievements Transformation Special Fund of Jiangsu Province · Scientific and Technological Innovation Special Fund for Carbon Peak and Carbon Neutrality of Jiangsu Province · International Collaboration Research Program of Nanjing City · Gusu Leading Talent Program of Scientific and Technological Innovation and Entrepreneurship

References (75)

Show source-provided references
1. 10.1002/smll.20150275610.1002/smll.201502756 ↗
2. 10.7150/thno.2257310.7150/thno.22573 ↗
3. 10.1002/adfm.20180830610.1002/adfm.201808306 ↗
4. 10.1002/advs.20180051010.1002/advs.201800510 ↗
5. 10.1073/pnas.141658111210.1073/pnas.1416581112 ↗
6. 10.1126/sciadv.aap997710.1126/sciadv.aap9977 ↗
7. 10.1038/s41467-019-10483-810.1038/s41467-019-10483-8 ↗
8. 10.1021/acs.chemrev.9b0044510.1021/acs.chemrev.9b00445 ↗
9. 10.1016/j.smaim.2022.11.00610.1016/j.smaim.2022.11.006 ↗
10. 10.1016/j.bioactmat.2021.09.01610.1016/j.bioactmat.2021.09.016 ↗
11. 10.1016/j.jconrel.2022.03.05910.1016/j.jconrel.2022.03.059 ↗
12. 10.1016/j.apsb.2021.05.03110.1016/j.apsb.2021.05.031 ↗
13. 10.1039/C1CS15179G10.1039/C1CS15179G ↗
14. 10.1021/ja038327y10.1021/ja038327y ↗
15. 10.1038/ncomms1109010.1038/ncomms11090 ↗
16. 10.1039/C7NR01667K10.1039/C7NR01667K ↗
17. 10.1021/acs.jpcc.0c0383710.1021/acs.jpcc.0c03837 ↗
18. 10.1021/ja209239m10.1021/ja209239m ↗
19. 10.1021/jacs.4c0313510.1021/jacs.4c03135 ↗
20. 10.1021/cr300179f10.1021/cr300179f ↗
21. 10.1073/pnas.26242779910.1073/pnas.262427799 ↗
22. 10.1021/acs.bioconjchem.2c0053410.1021/acs.bioconjchem.2c00534 ↗
23. 10.1002/anie.20181029710.1002/anie.201810297 ↗
24. 10.1016/0927-0256(96)00008-010.1016/0927-0256(96)00008-0 ↗
25. 10.1103/PhysRevB.49.1425110.1103/PhysRevB.49.14251 ↗
26. 10.1088/0953-8984/22/25/25320210.1088/0953-8984/22/25/253202 ↗
27. 10.1002/jcc.2175910.1002/jcc.21759 ↗
28. 10.1107/S002188981103897010.1107/S0021889811038970 ↗
29. 10.1002/jcc.2125610.1002/jcc.21256 ↗
30. 10.1517/17460441.2010.48446010.1517/17460441.2010.484460 ↗
31. 10.1021/ct300418h10.1021/ct300418h ↗
32. 10.3389/fmolb.2021.62701510.3389/fmolb.2021.627015 ↗
33. 10.1021/acsnano.0c0391610.1021/acsnano.0c03916 ↗
34. 10.1038/s41467-024-50769-010.1038/s41467-024-50769-0 ↗
35. 10.1002/adma.20170474910.1002/adma.201704749 ↗
36. 10.1038/ncomms831510.1038/ncomms8315 ↗
37. 10.1002/anie.20151203810.1002/anie.201512038 ↗
38. 10.1002/smll.20170082310.1002/smll.201700823 ↗
39. 10.1021/acsami.1c1872710.1021/acsami.1c18727 ↗
40. 10.1002/anie.20240082910.1002/anie.202400829 ↗
41. 10.1016/j.cej.2023.14401410.1016/j.cej.2023.144014 ↗
42. 10.1021/bc100501510.1021/bc1005015 ↗
43. 10.1038/s41524-021-00618-110.1038/s41524-021-00618-1 ↗
44. Clogston J. D. · 2011 · 6310.1007/978-1-60327-198-1_6 ↗
45. 10.1038/s41467-018-04873-710.1038/s41467-018-04873-7 ↗
46. 10.1002/anie.20191367510.1002/anie.201913675 ↗
47. 10.1021/acsnano.3c1043210.1021/acsnano.3c10432 ↗
48. 10.2147/IJN.S18479210.2147/IJN.S184792 ↗
49. 10.1016/j.ceramint.2018.08.04510.1016/j.ceramint.2018.08.045 ↗
50. 10.1016/j.msec.2014.11.01810.1016/j.msec.2014.11.018 ↗
51. 10.1016/j.msec.2015.10.00210.1016/j.msec.2015.10.002 ↗
52. 10.1016/j.biomaterials.2007.07.02910.1016/j.biomaterials.2007.07.029 ↗
53. 10.1088/0957-4484/20/11/11510310.1088/0957-4484/20/11/115103 ↗
54. 10.1021/acsami.7b0290010.1021/acsami.7b02900 ↗
55. 10.1002/adma.20150379910.1002/adma.201503799 ↗
56. 10.1039/D0OB02079F10.1039/D0OB02079F ↗
57. 10.1016/j.ceb.2009.09.00210.1016/j.ceb.2009.09.002 ↗
58. 10.3390/biomedicines1009208810.3390/biomedicines10092088 ↗
59. 10.1038/onc.2010.18910.1038/onc.2010.189 ↗
60. 10.1186/s13045-018-0609-110.1186/s13045-018-0609-1 ↗
61. 10.1158/0008-5472.CAN-21-408710.1158/0008-5472.CAN-21-4087 ↗
62. 10.1186/s12935-022-02645-410.1186/s12935-022-02645-4 ↗
63. 10.1186/bcr307710.1186/bcr3077 ↗
64. 10.1016/j.ccr.2014.02.02510.1016/j.ccr.2014.02.025 ↗
65. 10.1038/nrc330910.1038/nrc3309 ↗
66. 10.1159/00027938810.1159/000279388 ↗
67. 10.1038/s41596-024-01009-810.1038/s41596-024-01009-8 ↗
68. 10.1002/pro.65510.1002/pro.655 ↗
69. 10.1038/s41467-022-35015-910.1038/s41467-022-35015-9 ↗
70. 10.1002/jcc.2422710.1002/jcc.24227 ↗
71. 10.2174/15734091179567760210.2174/157340911795677602 ↗
72. 10.26508/lsa.20180015010.26508/lsa.201800150 ↗
73. 10.1002/adma.20190344310.1002/adma.201903443 ↗
74. 10.34133/cbsystems.002210.34133/cbsystems.0022 ↗
75. 10.1016/j.cej.2024.15450010.1016/j.cej.2024.154500 ↗